Support teaching, research, and patient care.
Trial ID: NCT00186290
Fractionated Total Body Irradiation (FTBI), Etoposide (VP-16) and Cyclophosphamide (CY) Followed by Allogeneic Bone Marrow Transplantation for Patients With Advanced Leukemia or High Grade Lymphoma
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Inclusion Criteria:HLA identical donor
- adequate organ function
- other life threatening disease
ablative allogeneic hematopoietic cell transplantation
School of Medicine
300 Pasteur Drive
Receive email alerts when trials open to patients.
©2022 Stanford Medicine